Sarepta疗法 SRPT 深 沪
等待开盘 02-07 09:30:00 美东时间
18.515
+1.485
+8.72%
华盛通- 最 高24.68
- 今 开17.59
- 成交量 274.30万股
- 最 低 16.895
- 昨 收 17.03
- 总市值 162.01万
- 52周最高 24.68
- 市盈率 静 --
- 换手率 3134.79%
- 52周最低 0.00
- 委 比 78.56%
- 总股本 8.75万
- 历史最高 24.68
- 量 比 0.98
- 振 幅 45.71%
- 历史最低 0.00
- 每 手 1
- 风险率 28.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Natural Gas Rallies 30%, Silver Jumps 13% To $116: What's Moving Markets Monday?
Natural gas jumps over 30% on winter storm disruptions, silver posts its biggest daily surge since 2008, and stocks grind higher.
01-27 02:26
Sarepta Says Elevidys Slows Duchenne Progression After Three Years
Sarepta's Elevidys shows significant improvement in motor function measures after three years of treatment, with no new safety signals.
01-26 22:26
Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements
Dyne Therapeutics reported positive results from Phase 1/2 DELIVER trial for z-rostudirsen in DMD amenable to exon 51 skipping.
2025-12-09 02:37
Silver Soars Past $58, Bitcoin-Strategy Bloodbath Deepens: What's Moving Markets Monday?
Wall Street kicked off December with stocks slightly easing after a strong late-November rally, as rising global bond yields and sharp moves in commodities and crypto set a more cautious tone for equity traders.
2025-12-02 02:25
Arrowhead Pharmaceuticals Earns $200M Milestone Payment From Sarepta Therapeutics
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The milestone was earned when Arrowhead achieved the second
2025-11-24 20:31
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.
2025-11-15 06:48
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock.
2025-11-05 01:11
Market-Moving News for November 4th
PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patients With Myeloproliferative Neoplasms NSP: -32% | Insperity shares are trading
2025-11-04 20:24
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
2025-11-03 22:14
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
